After several postponed decisions, Mylan Inc (MYL) has announced that it is moving forward with a Botox biosimilar development program in collaboration with …
Silicon Valley biotech Revance Therapeutics (RVNC) has announced the signing of a definitive agreement to acquire Hint, Inc, a private company which has …
Biotech stocks require only a few select indicators to send a share price soaring, or conversely, to cause it to tumble mercilessly down …
Guggenheim analyst Rohit Vanjani has initiated coverage of the dermatology space, announcing ratings on four pharmaceuticals stocks. We don’t have time to cover …
Guggenheim’s Rohit Vanjani puts a price tag on Revance Therapeutics.
